Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Ciba-Geigy
|
| gptkbp:brand |
Ativan
Ativan Injection Ativan Oral Solution Lorazepam Intensol Temesta |
| gptkbp:category |
gptkb:D
not recommended |
| gptkbp:class |
anxiolytic
sedative-hypnotic |
| gptkbp:contraindication |
gptkb:Insurance_Company
severe respiratory insufficiency acute narrow-angle glaucoma |
| gptkbp:dependency |
moderate to high
|
| gptkbp:developed_by |
gptkb:Wyeth_Pharmaceuticals
|
| gptkbp:duration |
short-term
|
| gptkbp:form |
gptkb:tablet
injection oral solution |
| https://www.w3.org/2000/01/rdf-schema#label |
Lorazepam
|
| gptkbp:ingredients |
C15 H10 Cl2 N2 O2
|
| gptkbp:interacts_with |
gptkb:beer
antihistamines antidepressants opioids muscle relaxants |
| gptkbp:is_atype_of |
N05 B A06
|
| gptkbp:is_used_for |
anxiety
insomnia sedation seizure disorders |
| gptkbp:legal_issue |
prescription only
|
| gptkbp:lifespan |
10 to 20 hours
|
| gptkbp:manager |
oral
intravenous intramuscular |
| gptkbp:metabolism |
liver
|
| gptkbp:risk_factor |
high
|
| gptkbp:side_effect |
dizziness
nausea confusion weakness drowsiness |
| gptkbp:symptoms |
anxiety
seizures insomnia |
| gptkbp:type_of |
846-49-1
|
| gptkbp:year_created |
gptkb:1963
|